SUBSCRIBE
SUBSCRIBE
News   FDA

Genentech’s (JOBS) Psoriasis Drug Raptiva Gets FDA Warning

October 17, 2008 | 
1 min read
WASHINGTON, Oct 16 (Reuters) - U.S. health regulators have ordered strong black-box warnings for Genentech Inc's psoriasis drug, Raptiva, saying patients given the once-weekly injections are at risk for life-threatening infections.
FDA Approvals
Genentech, Inc. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Podcast
Pfizer and Novo Battle Over Metsera, Tidmarsh Fights FDA Exit, UniQure and Sarepta Face Setbacks
November 5, 2025
 · 
1 min read
 · 
Heather McKenzie
Poster sketch image artwork photo collage of body language finger showing gesture symbol thumb down dislike dissatisfied minus no opinion.
Rare diseases
Biohaven Cuts R&D Spending by 60% After FDA Rejection of Drug for Rare Neurodegenerative Disease
November 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Female hand showing thumbs up gesture on blue background, art collage. Positive hand sign. Fashion collage in the style of Thumbs up magazine. Contemporary art. Modern design.
Rare diseases
UCB Wins First FDA Approval for Ultra-Rare Mitochondrial Disease
November 4, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA CDER director George Tidmarsh speaking in an FDA video
FDA
UPDATE: Tidmarsh Waffles on Resignation, Will Fight To Clear Name
November 3, 2025
 · 
3 min read
 · 
Tristan Manalac